Profil
William Bauta currently works at bioAffinity Technologies, Inc., as Chief Science Officer from 2024.
Dr. Bauta also formerly worked at Genzyme Corp., as Associate Director-Science.
Dr. Bauta received his doctorate degree from The University of Chicago.
Postes actifs de William Bauta
| Sociétés | Poste | Début |
|---|---|---|
| BIOAFFINITY TECHNOLOGIES, INC. | Directeur Technique/Scientifique/R&D | 04/11/2024 |
Anciens postes connus de William Bauta
| Sociétés | Poste | Fin |
|---|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
Formation de William Bauta
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc. Medical SpecialtiesHealth Technology Develops vitro diagnostic tests and targeted cancer therapeutics for early-stage cancer diagnostics | Health Technology |
















